{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:20:40Z","timestamp":1707524440024},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,8]]},"DOI":"10.7759\/cureus.22019","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T14:07:49Z","timestamp":1644329269000},"source":"Crossref","is-referenced-by-count":1,"title":["Polypharmacy in a Patient With Intellectual and Developmental Disabilities"],"prefix":"10.7759","author":[{"given":"Rishi","family":"Raj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Owen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshmi","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ummerubab","family":"Syeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/genes10090713","article-title":"The global Prader-Willi syndrome registry: development, launch, and early demographics","volume":"10","author":"Bohonowych J","year":"2019","unstructured":"Bohonowych J, Miller J, McCandless SE, Strong TV. The global Prader-Willi syndrome registry: development, launch, and early demographics. Genes (Basel). 2019, 10:713. 10.3390\/genes10090713","journal-title":"Genes (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1352\/1944-7558-125.1.37","article-title":"Adverse Medication Events Related to Hospitalization in the United States: A Comparison Between Adults With Intellectual and Developmental Disabilities and Those Without","volume":"125","author":"Erickson SR","year":"2020","unstructured":"Erickson SR, Kamdar N, Wu CH. Adverse Medication Events Related to Hospitalization in the United States: A Comparison Between Adults With Intellectual and Developmental Disabilities and Those Without. Am J Intellect Dev Disabil. 2020, 125:37-48. 10.1352\/1944-7558-125.1.37","journal-title":"Am J Intellect Dev Disabil"},{"key":"ref3","article-title":"Primary care of adults with intellectual and developmental disabilities: 2018 Canadian consensus guidelines","volume":"64","author":"Sullivan WF","year":"2018","unstructured":"Sullivan WF, Diepstra H, Heng J, et al.. Primary care of adults with intellectual and developmental disabilities: 2018 Canadian consensus guidelines. Can Fam Physician. 2018, 64:254-79.","journal-title":"Can Fam Physician"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320350306","article-title":"Prader-Willi syndrome: current understanding of cause and diagnosis","volume":"35","author":"Butler MG","year":"1990","unstructured":"Butler MG. Prader-Willi syndrome: current understanding of cause and diagnosis. Am J Med Genet. 1990, 35:319-32. 10.1002\/ajmg.1320350306","journal-title":"Am J Med Genet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/gim.0b013e31822bead0","article-title":"Prader-Willi syndrome","volume":"14","author":"Cassidy SB","year":"2012","unstructured":"Cassidy SB, Schwartz S, Miller JL, Driscoll DJ. Prader-Willi syndrome. Genet Med. 2012, 14:10-26. 10.1038\/gim.0b013e31822bead0","journal-title":"Genet Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2147\/IPRP.S64535","article-title":"Polypharmacy in pediatric patients and opportunities for pharmacists' involvement","volume":"4","author":"Horace AE","year":"2015","unstructured":"Horace AE, Ahmed F. Polypharmacy in pediatric patients and opportunities for pharmacists' involvement. Integr Pharm Res Pract. 2015, 4:113-26. 10.2147\/IPRP.S64535","journal-title":"Integr Pharm Res Pract"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ridd.2014.07.060","article-title":"Prevalence and factors associated with polypharmacy in Victorian adults with intellectual disability","volume":"35","author":"Haider SI","year":"2014","unstructured":"Haider SI, Ansari Z, Vaughan L, Matters H, Emerson E. Prevalence and factors associated with polypharmacy in Victorian adults with intellectual disability. Res Dev Disabil. 2014, 35:3071-80. 10.1016\/j.ridd.2014.07.060","journal-title":"Res Dev Disabil"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010505","article-title":"Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study","volume":"6","author":"O'Dwyer M","year":"2016","unstructured":"O'Dwyer M, Peklar J, McCallion P, McCarron M, Henman MC. Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study. BMJ Open. 2016, 6:e010505. 10.1136\/bmjopen-2015-010505","journal-title":"BMJ Open"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ridd.2015.11.017","article-title":"Adverse events and the relation with quality of life in adults with intellectual disability and challenging behaviour using psychotropic drugs","volume":"49-50","author":"Scheifes A","year":"2016","unstructured":"Scheifes A, Walraven S, Stolker JJ, Nijman HL, Egberts TC, Heerdink ER. Adverse events and the relation with quality of life in adults with intellectual disability and challenging behaviour using psychotropic drugs. Res Dev Disabil. 2016, 49-50:13-21. 10.1016\/j.ridd.2015.11.017","journal-title":"Res Dev Disabil"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1108\/AMHID-02-2018-0004","article-title":"Stopping over-medication of people with intellectual disability, autism or both (STOMP) in England part 1 - history and background of STOMP","volume":"13","author":"Branford D","year":"2019","unstructured":"Branford D, Gerrard D, Saleem N, et al.. Stopping over-medication of people with intellectual disability, autism or both (STOMP) in England part 1 - history and background of STOMP. Adv Ment Health Intellect Disabil. 2019, 13:31-40. 10.1108\/AMHID-02-2018-0004","journal-title":"Adv Ment Health Intellect Disabil"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2020.97","article-title":"UK psychiatrists' experience of withdrawal of antipsychotics prescribed for challenging behaviours in adults with intellectual disabilities and\/or autism","volume":"6","author":"Deb S","year":"2020","unstructured":"Deb S, Nancarrow T, Limbu B, et al.. UK psychiatrists' experience of withdrawal of antipsychotics prescribed for challenging behaviours in adults with intellectual disabilities and\/or autism. BJPsych Open. 2020, 6:e112. 10.1192\/bjo.2020.97","journal-title":"BJPsych Open"},{"key":"ref12","article-title":"Health checks for adults with intellectual and developmental disabilities in a family practice","volume":"64","author":"Casson I","year":"2018","unstructured":"Casson I, Broda T, Durbin J, et al.. Health checks for adults with intellectual and developmental disabilities in a family practice. Can Fam Physician. 2018, 64:S44-50.","journal-title":"Can Fam Physician"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/85753-polypharmacy-in-a-patient-with-intellectual-and-developmental-disabilities","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:44:11Z","timestamp":1707507851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/85753-polypharmacy-in-a-patient-with-intellectual-and-developmental-disabilities"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,8]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.22019","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,8]]}}}